HHV8 ORF50 Polyclonal Antibody, Cy3 Conjugated
Product Specifications
Background
HHV8 has been found to be associated with three different diseases observed in AIDS patients; kaposi's sarcoma, primary effusion lymphoma (which is a rare type of non-Hodgkin lymphoma affecting the body cavities) and multicentric Castleman's disease. To date there is much evidence to support a direct role for HHV8 in kaposi's sarcoma.
Synonyms
HHV8 ORF50; HHV 8; Human Herpes Virus 8; Human herpesvirus 8; Kaposi's sarcoma associated herpes virus; Kaposi's sarcoma associated herpesvirus; KSHV; replication and transcription activator; RTA
Gene ID
4961526
Swiss Prot
F5HCV3
Host
Rabbit
Cross Reactivity
Virus
Immunogen
601-691/691
Target
HHV8 ORF50
Clonality
Polyclonal
Isotype
IgG
Conjugation
Cy3
Source
KLH conjugated synthetic peptide derived from C-terminus of HHV8 ORF50 strain GK18
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
512,550nm/570,615nm
Concentration
1µg/µl
Dilution
WB (1:500-1000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
4961526
Cross Reactivity Details
Human herpesvirus 8, Kaposi's sarcoma-associated herpesvirus
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC680050-500 1x 500 µL
IgA Secretory Component (SC05), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400965-500 1x 500 µL
MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (VU-11D1), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680276-500 1x 500 µL
TAG-72 / CA72.4 (B72.3), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 